Heparin-induced thrombocytopenia

Clinical Toxicology

Volumn 52, Issue 6, 2014, Pages 579-583

  Lovecchio, F ^a  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

Heparin; Heparin induced thrombocytopenia

Indexed keywords

HEPARIN; THROMBIN;

CONFERENCE PAPER; DIAGNOSTIC TEST; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARINIZATION; HUMAN; PATHOPHYSIOLOGY; PLATELET MICROPARTICLE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE MEMBRANE;

HEPARIN; HEPARIN-INDUCED THROMBOCYTOPENIA;

ANTIBODIES; HEPARIN; HUMANS; THROMBOCYTOPENIA;

EID: 84903163925     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2014.917181     Document Type: Conference Paper

References (26)

1. Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: E495S-e530S.
2. Warkentin TE, Greinacher A, Koster A, Lincoff AM, American College of Chest Physicians. Treatment and prevention of heparininduced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 340S-380S.
3. C hong B H, C astaldi P A. P latelet proaggregating effect of heparin: Possible mechanism for non-immune heparin-Associated thrombocytopenia . Aust N Z J Med 1986; 16: 715-716.
4. Greinacher A. Antigen generation in heparin-Associated thrombocytopenia: The nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 1995; 21: 106-116.
5. Stanton PE Jr, Evans JR, Lefemine AA, Vo NM, Rannick GA, Morgan CV Jr, et al. White clot syndrome. South Med J 1988; 81: 616-620.
6. Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update. Thromb Res 2006; 118: 165-176. (Pubitemid 43816669)
7. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-Analysis. Blood 2005; 106: 2710-2715. (Pubitemid 41510744)
8. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335.
9. Crespo EM, Oliveira GB, Honeycutt EF, Becker RC, Berger PB, Moliterno DJ, et al. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J 2009; 157: 651-657.
10. P randoni P, S iragusa S, G irolami B, F abris F, B ELZONI Investigators Group. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: A prospective cohort study. Blood 2005; 106: 3049-3054.
11. Muslimani AA, Ricaurte B, Daw HA. Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter fl ushes. Am J Hematol 2007; 82: 652-655. (Pubitemid 47015292)
12. Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: Diagnostic and therapeutic implications . Blood 2006; 107: 2346-2353. (Pubitemid 43345554)
13. Greinacher A, Kohlmann T, Strobel U, Sheppard JA, Warkentin TE. The temporal profile of the anti-PF4/heparin immune response. Blood 2009; 113: 4970-4976.
14. Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med 2002; 136: 210-215. (Pubitemid 34118121)
15. Gruel Y, Pouplard C. Post-operative platelet count profile: The most reliable tool for identifying patients with true heparin-induced thrombocypenia after cardiac surgery. J Thromb Haemost 2010; 8: 27-29.
16. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101: 502-507. (Pubitemid 126335970)
17. Warkentin TE, Roberts RS, Hirsh J, Kelton JG. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: A nested cohort study. Chest 2005; 127: 1857-1861. (Pubitemid 46218820)
18. Tietge UJ, Schmidt HH, J ä ckel E, Trautwein C, Manns MP. Low molecular weight heparin-induced skin necrosis occurring distant from injection sites and without thrombocytopenia. J Intern Med 1998; 243: 313-315. (Pubitemid 28234404)
19. Cuker A, Gimotty PA, Mark A, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: A systematic review and meta-Analysis. Blood 2012; 120: 4160-4167.
20. Harenberg J, Huhle G, Giese C, Wang LC, Feuring M, Song XH, Hoffmann U. Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia . Br J Haematol 2000; 109: 182-186. (Pubitemid 30340595)
21. Napolitano LM, Warkentin TE, Almahameed A, et al. Heparininduced thrombocytopenia in the critical care setting: Diagnosis and management. Crit Care Med. 2006; 34: 2898.
22. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia . Thromb Haemost 1993; 69: 344-345.
23. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101: 502-507. (Pubitemid 126335970)
24. Lubenow N, Eichler P, Lietz T, Farner B, Greinacher A. Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparininduced thrombocytopenia: An analysis of 3 prospective studies. Blood 2004; 104: 3072-3077. (Pubitemid 39507121)
25. G ruel Y, P ouplard C, N guyen P, B org J Y, D erlon A, J uhan-Vague I, et al. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia. Br J Haematol 2003; 121: 786-792.
26. Wallis DE, Workman DL, Lewis BE, Steen L, Pifarre R, Moran JF. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 1999; 106: 629-635. (Pubitemid 29279299)